Nicox launches expanded access to Sequenom’s RetnaGene tests in U.S.

Article

Nicox Inc. is launching expanded access to Sequenom Laboratories’ RetnaGene portfolio of genetic tests-RentaGene AMD and RetnaGene LR-which asses an individual’s risk for advanced age-related macular degeneration (AMD).

San Diego, CA-Nicox Inc. is launching expanded access to Sequenom Laboratories’ RetnaGene portfolio of genetic tests-RentaGene AMD and RetnaGene LR-which asses an individual’s risk for advanced age-related macular degeneration (AMD).

“The RetnaGene tests allow for improved patient management, by examining the most relevant genetic markers for a more accurate prediction of advanced AMD risk,” says Jerry St. Peter, executive vice president and general manager of Nicox Inc.

The tests collect DNA specimens with an in-office buccal swab. In January 2014, Sequenom Laboratories granted Nicox exclusive promotion and marketing rights for its RetnaGene tests.

“Currently there is much debate in the medical community surrounding the best way to incorporate genetic testing for AMD into clinical practice. Expanded access to the RetnaGene tests will provide broader use and education to clinicians about this important technology,” said Quan Dong Nguyen, MD, MSc, who holds the McGaw Memorial Endowed Chair in Ophthalmology and is the inaugural director of the Truhlsen Eye Institute, University of Nebraska Medical Center.

Related: AMD genetic testing could lead to early diagnosis, better treatment 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD, and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
© 2025 MJH Life Sciences

All rights reserved.